Literature DB >> 11466400

MHC class I-restricted determinants on the glutamic acid decarboxylase 65 molecule induce spontaneous CTL activity.

A Quinn1, M F McInerney, E E Sercarz.   

Abstract

CD4(+) T cell responses to glutamic acid decarboxylase (GAD65) spontaneously arise in nonobese diabetic (NOD) mice before the onset of insulin-dependent diabetes mellitus (IDDM) and may be critical to the pathogenic process. However, since both CD4(+) and CD8(+) T cells are involved in autoimmune diabetes, we sought to determine whether GAD65-specific CD8(+) T cells were also present in prediabetic NOD mice and contribute to IDDM. To refine the analysis, putative K(d)-binding determinants that were proximal to previously described dominant Th determinants (206-220 and 524-543) were examined for their ability to elicit cytolytic activity in young NOD mice. Naive NOD spleen cells stimulated with GAD65 peptides 206-214 (p206) and 546-554 (p546) produced IFN-gamma and showed Ag-specific CTL responses against targets pulsed with homologous peptide. Conversely, several GAD peptides distal to the Th determinants, and control K(d)-binding peptides did not induce similar responses. Spontaneous CTL responses to p206 and p546 were mediated by CD8(+) T cells that are capable of lysing GAD65-expressing target cells, and p546-specific T cells transferred insulitis to NOD.scid mice. Young NOD mice pretreated with p206 and p546 showed reduced CTL responses to homologous peptides and a delay in the onset of IDDM. Thus, MHC class I-restricted responses to GAD65 may provide an inflammatory focus for the generation of islet-specific pathogenesis and beta cell destruction. This report reveals a potential therapeutic role for MHC class I-restricted peptides in treating autoimmune disease and revisits the notion that the CD4- and CD8-inducing determinants on some molecules may benefit from a proximal relationship.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11466400     DOI: 10.4049/jimmunol.167.3.1748

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Adoptive Transfer of mRNA-Transfected T Cells Redirected against Diabetogenic CD8 T Cells Can Prevent Diabetes.

Authors:  Sigal Fishman; Mark D Lewis; L Khai Siew; Evy De Leenheer; Dimitri Kakabadse; Joanne Davies; Doron Ziv; Alon Margalit; Nathan Karin; Gideon Gross; F Susan Wong
Journal:  Mol Ther       Date:  2017-01-18       Impact factor: 11.454

2.  Development of a Bioconjugate Platform for Modifying the Immune Response of Autoreactive Cytotoxic T Lymphocytes Involved in Type 1 Diabetes.

Authors:  Neha Nandedkar-Kulkarni; Abhishek R Vartak; Steven J Sucheck; Katherine A Wall; Anthony Quinn; Michael P Morran; Marcia F McInerney
Journal:  Bioconjug Chem       Date:  2019-07-05       Impact factor: 4.774

3.  Disabling an integral CTL epitope allows suppression of autoimmune diabetes by intranasal proinsulin peptide.

Authors:  Nathan R Martinez; Petra Augstein; Antonis K Moustakas; George K Papadopoulos; Silvia Gregori; Luciano Adorini; David C Jackson; Leonard C Harrison
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

4.  GAD65-Specific Cytotoxic T Lymphocytes Mediate Beta-Cell Death and Loss of Function.

Authors:  Sarah Rasche; Rhea Y Busick; Anthony Quinn
Journal:  Rev Diabet Stud       Date:  2009-05-10

Review 5.  Translational mini-review series on type 1 diabetes: Systematic analysis of T cell epitopes in autoimmune diabetes.

Authors:  T P Di Lorenzo; M Peakman; B O Roep
Journal:  Clin Exp Immunol       Date:  2007-04       Impact factor: 4.330

6.  Impairment by sperm agglutinating factor isolated from Escherichia coli: receptor specific interactions.

Authors:  Kiranjeet Kaur; Vijay Prabha
Journal:  Biomed Res Int       Date:  2013-07-17       Impact factor: 3.411

7.  Cathepsin L inhibition prevents murine autoimmune diabetes via suppression of CD8(+) T cell activity.

Authors:  Akiko Yamada; Naozumi Ishimaru; Rieko Arakaki; Nobuhiko Katunuma; Yoshio Hayashi
Journal:  PLoS One       Date:  2010-09-22       Impact factor: 3.240

8.  T-cell vaccination leads to suppression of intrapancreatic Th17 cells through Stat3-mediated RORγt inhibition in autoimmune diabetes.

Authors:  Min Wang; Liu Yang; Xiaoyan Sheng; Weilei Chen; Haiqing Tang; Hongguang Sheng; Beili Xi; Ying Qin Zang
Journal:  Cell Res       Date:  2011-04-26       Impact factor: 46.297

9.  Activation of insulin-reactive CD8 T-cells for development of autoimmune diabetes.

Authors:  F Susan Wong; Lai Khai Siew; Gwen Scott; Ian J Thomas; Stephen Chapman; Christophe Viret; Li Wen
Journal:  Diabetes       Date:  2009-02-10       Impact factor: 9.461

10.  Normal incidence of diabetes in NOD mice tolerant to glutamic acid decarboxylase.

Authors:  Elmar Jaeckel; Ludger Klein; Natalia Martin-Orozco; Harald von Boehmer
Journal:  J Exp Med       Date:  2003-06-09       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.